Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Drug Delivery
Filter     Order     Display # 
Date Item Title
15 Nov 2006 Pharmos Completes Phase 1 Study of Topical Diclofenac NanoEmulsion Cream
09 Nov 2006 Emisphere Reports Additional Clinical Data From Phase 2 Oral Insulin Trial
08 Nov 2006 Lux Biosciences Announces Exclusive Worldwide License Agreement With National Institutes of Health (NIH) For Late Stage Ophthalmic Product
02 Nov 2006 Apollo Life Sciences Begins Tests of Breakthrough Oral TNF Blocker for Arthritis
01 Nov 2006 NovaDel Announces Positive Results from Pilot Study of Zolpidem Oral Spray vs. Ambien(R) Tablets
31 Oct 2006 Adolor Corporation Discontinues Development of Sterile Lidocaine Patch
20 Oct 2006 DURECT Provides an Update to the Memryte™ Program Under Development by Voyager Pharmaceutical Corp.
18 Oct 2006 YM BioSciences announces results of AeroLEF(TM) Phase IIb open-label study
17 Oct 2006 Apollo Develops Topical Treatment for Psoriasis, Eliminating Need for Injections
11 Oct 2006 Cephalon Announces Positive Results for FENTORA(TM) (fentanyl buccal tablet) for Breakthrough Pain in Patients with Chronic Low Back Pain
10 Oct 2006 SCHWARZ PHARMA Reports Positive Results for Rotigotine in Restless Legs Syndrome
05 Oct 2006 Skyepharma PLC (SKYE) Reports Positive Phase III And EU Filing For Lodotra(TM)
30 Sep 2006 Labopharm Receives Approvable Letter From Fda For Once-Daily Tramadol
29 Sep 2006 Sonus Pharmaceuticals Initiates Phase 1 Clinical Trial for Company’s Second Anti-cancer Drug, TOCOSOL® Camptothecin
28 Sep 2006 YM Biosciences Announces Aerolef(TM) Phase IIb Interim Review
28 Sep 2006 Nitec Pharma Reports Positive Phase III Results and Filing in EU for Lodotra(TM)
27 Sep 2006 Dermisonics' Test With Type-2 Diabetics Proves Insulin Patch Component of the U-Strip System Does Not Damage the Skin
27 Sep 2006 Axcan Pharma And AGI Therapeutics plc Sign Exclusive License And Co-Development Agreement For The Next-Generation Therapy For GERD And The Control Of Nocturnal Acid Breakthrough; Deal Worth US $19M
26 Sep 2006 Cephalon Receives FDA Approval of FENTORA(TM) (fentanyl buccal tablet) for the Management of Breakthrough Pain in Patients with Cancer
23 Sep 2006 Alexza Initiates Phase IIa Clinical Trial for AZ-004 in Schizophrenic Patients With Acute Agitation
20 Sep 2006 Bentley Pharmaceuticals Announces Agreement with Cardinal Health for Scale-Up and Manufacture of Clinical Supplies for Bentley's Intranasal Insulin Program
20 Sep 2006 Novavax Initiates Pre-Clinical Testing of Intranasal Influenza Vaccine
20 Sep 2006 BioAlliance Pharma announces final results of its doxorubicin Transdrug Phase I/II clinical trial for primary liver cancer
20 Sep 2006 Nastech Initiates Clinical Development of Rapid Acting Insulin Nasal Spray for Diabetes
19 Sep 2006 Type 2 Diabetes Patients on Technosphere Insulin Exhibited No Adverse Effect on Pulmonary Function with Significant HbA1c Reductions, and Showed Significant Weight Reduction Compared to Injected Insulin Analog
15 Sep 2006 MannKind Corporation Completes Patient Enrollment for the Major Phase 3 Safety Study of Technosphere(R) Insulin in Patients With Diabetes
15 Sep 2006 Drug Delivery specialist celares GmbH starts extensive contract development for Max-Planck-Institute for Infection Biology.
14 Sep 2006 Exubera Effective in Diabetes Patients who Have Respiratory Infections or are Exposed to Passive Cigarette Smoke, New Analyses Show
14 Sep 2006 NovaDel Announces Two CNS Oral Spray Drug Candidates in its Development Pipeline; Oral Spray Formulations of Tizanidine for Spasticity and Ropinirole for Parkinson's Disease
13 Sep 2006 ConjuChem Discloses Final Results Of PC-DAC:Exendin-4 Phase I/II Trial For Type 2 Diabetes - Update
13 Sep 2006 SurModics I-vation(TM) Intravitreal Implant Six Month Clinical Study Data Presented at the American Society of Retina Specialists Meeting; Well Tolerated, 100% of Patients Maintained or Improved Vision
12 Sep 2006 Iomai Receives FDA Clearance for Study Comparing Novel Flu Vaccine Patch to Traditional Injectable Vaccine
12 Sep 2006 Cipher Reports Results From Phase III Trial For CIP-TRAMADOL ER
06 Sep 2006 Emisphere's eligen(R) Technology Demonstrates Delivery of Active Recombinant Human Growth Hormone
06 Sep 2006 Cipher's CIP-TRAMADOL ER New Drug Application Accepted For Review
06 Sep 2006 SCHWARZ PHARMA's Parkinson Patch Offers Additional Benefits
06 Sep 2006 MAP Pharmaceuticals Initiates Phase 2 Clinical Trial in Patients With Migraine
05 Sep 2006 Orexo´s licensing partner submits registration file for the pain product Rapinyl
31 Aug 2006 NovaDel Announces FDA Acceptance of Zensana(TM) NDA For Review
31 Aug 2006 Commencement of INX-0125 Phase 1 Clinical Trial
23 Aug 2006 Fresenius Kabi and Sandoz to cooperate in the development of an HESylated biopharmaceutical drug
18 Aug 2006 EpiCept Completes Patient Enrollment in European Phase III Clinical Trial for LidoPain SP
17 Aug 2006 BEMA(TM) LA Achieves Therapeutic Plasma Concentrations in Phase I Trial: Complementary Pain Therapy to Phase III BEMA(TM) Fentanyl Product
16 Aug 2006 Statistically Significant Phase IIb Clinical Results Of Transport’s Drug/Device Combination Product For Herpes Labialis Published In Journal Of Clinical Infectious Diseases
11 Aug 2006 Vyteris Announces Positive Results in Two Phase I Clinical Trials for Treatment of Infertility; Data Indicate Actyve(TM) Transdermal Drug Delivery Achieves Therapeutic Levels Of A Peptide Used For Treatment Of Infertility In Humans
10 Aug 2006 Abeille Submits AB-1001 Phase III Pivotal Efficacy Study Protocol For FDA Review
10 Aug 2006 NexMed Develops Room Temperature Formulation of Alprox-TD for Erectile Dysfunction
09 Aug 2006 NovaDel Announces Initiation of Clinical Trial of Zolpidem Oral Spray; New Drug Application Expected in 2007
03 Aug 2006 Hana Biosciences Initiates Phase I Clinical Trial of a Targeted Chemotherapy Agent for Patients With Advanced Solid Tumors
03 Aug 2006 Biodel Inc. Raises $21 Million in Series B Financing; Top-Tier Healthcare Investors Provide Funding for Phase 3 Clinical Development of Viaject(TM) Rapid Acting Insulin for Type 1 and 2 Diabetes
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
Results 201 - 250 of 410

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics